Federal government, professional societies, and research centers.
Last week, The Cancer Letter spoke with Janice Cowden, a patient with metastatic breast cancer and symptoms of COVID-19—who was denied testing despite being especially vulnerable to the disease (The Cancer Letter, March 20).
Patients with Medicare and Medicaid coverage are unable to receive genetic counseling through telehealth, and The National Society of Genetic Counselors is urging Congress to act.
Four University of Nebraska Medical Center physicians who also have roles in the Global Center for Health Security at UNMC/Nebraska Medicine, recently released an open-access book about quarantine.
In light of the national shortage of one-use personal protective equipment, Nebraska Medicine has developed a safe and effective method to decontaminate these items so they can be used multiple times.
The Association of American Cancer Institutes has urged President Donald Trump to invoke the Defense Production Act to forcefully confront the COVID-19 emergency.
The following are statements from NCI on the state of clinical trials and funding during the COVID-19 pandemic.
The House of Representatives March 27 passed a $2 trillion coronavirus relief package to “prevent, prepare for, and respond to coronavirus, domestically or internationally.” The bill appropriates pandemic response funds in the following amounts: $4.3 billion for CDC, $945.4 million for NIH, $80 million for FDA, and $200 million for CMS.
